APO-go® (apomorphine hydrochloride)

Britannia Pharmaceuticals Limited

APO-go® information courtesy of Britannia Pharmaceuticals Limited

Last updated 25 July 2007

This section provides a summary of the drug information for APO-go® (apomorphine hydrochloride). It is still important that you read the full package leaflet that accompanies the product carefully before you start to take any medication.

If you have any further questions about your PD medication, or other aspects of your PD treatment, you should discuss these with your doctor or other healthcare professional.

  • APO-go® Pen (UK)

    APO-go® Pen (UK)

  • APO-go® Pens (UK)

    APO-go® Pens (UK)

  • APO-go® 50mg-5ml ampoules (UK)

    APO-go® 50mg-5ml ampoules (UK)

  • APO-go® 20mg-2ml ampoules (UK)

    APO-go® 20mg-2ml ampoules (UK)

  • APO-go® PFS (UK)

    APO-go® PFS (UK)

  •  

    Click on photos to enlarge

APO-go® is registered for use in the following countries
Australia AustraliaAustralia & New Zealand Apomine® Mayne Pharma
Austria Germany SwitzerlandAustria, Germany & Switzerland APO-go® Cephalon
GreeceGreece APO-go® ITF Hellas
HolandHolland APO-go® Apotheekzorg
IsraelIsrael APO-go® Teva
North AmericaNorth America Apokyn® Vernalis
Portugal SpainPortugal & Spain APO-go® Italfarmaco
Denmark Norway Sweden Finland Iceland Faeroe Islands Scandinavia APO-go® Nordic Infucare
IrelandRepublic of Ireland APO-go® Clonmel Healthcare Ltd
TurkeyTurkey APO-go® Gen Ilac
United KingdomUK APO-go® Britannia Pharmaceuticals Ltd
Top of page

Availability - Formulation

There are currently a maximum of three APO-go® presentations available. Approved presentations may vary between countries:

  • APO-go® PEN 10mg/ml
    (pens for injection)
  • APO-go®Ampoules 10mg/ml available in 2ml and 5ml ampoules
    (solution for injection)
  • APO-go®PFS 5mg/ml Solution for Infusion in Pre-filled Syringe
    ( Pre-filled Syringes)
Top of page

Downloads

The information on this page printout is a general summary of the APO-go® medication product.

Please click on the links below to download more detailed information on the specific APO-go® medication, its handling and use.

Links go to the electronic Medicines Compendium (eMC) website.

Further detailed information on the specific APO-go® medication, its handling and use can be downloaded via the electronic Medicines Compendium (eMC) website (http://emc.medicines.org.uk/):

UK Patient Information Leaflets

UK Summary of Product Characteristics

Please note that SPCs are designed for healthcare professionals.

Top of page

Useful Links & References

Top of page

Further Information

Britannia Pharmaceuticals Limited
41-51 Brighton Road
Redhill
Surrey
RH1 6YS
United Kingdom
t: +44 (0)1737 773741
f: +44 (0)1737 762672